Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma

被引:3
|
作者
Pasquini, Marcelo C. [1 ]
Le Rademacher, Jennifer [2 ]
Flowers, Christopher [3 ]
Lill, Michael [4 ]
Costa, Luciano J. [5 ]
Shore, Tsiporah B. [6 ]
Vaughan, William [7 ]
Craig, Michael [8 ]
Freytes, Cesar O. [9 ,10 ]
Shea, Thomas C. [11 ]
Horwitz, Mitchell E. [12 ]
Fay, Joseph W. [13 ]
Mineishi, Shin [14 ]
Rondelli, Damiano [15 ]
Mason, James [16 ]
Reddy, Vijay [17 ]
Braunschweig, Ira [18 ]
Ai, Weiyun [19 ]
Armstrong, Elizabeth [20 ]
Smith, Angela [20 ]
Zhao, Cathy [20 ]
Elekes, Agnes [20 ]
Carreras, Jeanette [1 ]
Kato, Kazunobu [20 ]
Waller, Edmund K. [3 ]
机构
[1] Med Coll Wisconsin, CIBMTR, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[3] Emory Univ, Div BMT, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[5] Med Univ S Carolina, Charleston, SC 29425 USA
[6] New York Hosp, Cornell Med Ctr Hematol Oncol, New York, NY 10021 USA
[7] Univ Alabama Birmingham, Bone Marrow Transplantat & Cell Therapy Program, Birmingham, AL USA
[8] W Virginia Univ, Hlth Sci Ctr, Morgantown, WV 26506 USA
[9] South Texas Vet Hlth Care Syst, San Antonio, TX USA
[10] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[11] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC USA
[12] Duke Univ, Med Ctr, Dept Med, Adult Stem Cell Transplant Program,Div Cellular T, Durham, NC 27710 USA
[13] Baylor Univ, Med Ctr, Dallas, TX USA
[14] Univ Alabama Birmingham, Bone Marrow Transplantat Program, Birmingham, AL USA
[15] Univ Illinois Hosp & Hlth Sci Syst, Dept Med, Sect Hematol Oncol, Chicago, IL USA
[16] Scripps Clin, La Jolla, CA 92037 USA
[17] Univ Florida, Gainesville, FL USA
[18] Montefiore Med Ctr, Bronx, NY 10467 USA
[19] Univ Calif San Francisco, San Francisco, CA 94143 USA
[20] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
关键词
D O I
10.1016/j.bbmt.2013.12.259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
232
引用
收藏
页码:S162 / S162
页数:1
相关论文
共 50 条
  • [21] CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients
    Tao Wang
    Ping Liu
    Lili Xu
    Lei Gao
    Xiong Ni
    Gusheng Tang
    Li Chen
    Jie Chen
    Libing Wang
    Yang Wang
    Weijia Fu
    Wenqin Yue
    Na Liu
    Ruobing Li
    Guihua Lu
    Yanrong Luo
    Jianmin Yang
    Annals of Hematology, 2024, 103 : 575 - 582
  • [22] CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients
    Wang, Tao
    Liu, Ping
    Xu, Lili
    Gao, Lei
    Ni, Xiong
    Tang, Gusheng
    Chen, Li
    Chen, Jie
    Wang, Libing
    Wang, Yang
    Fu, Weijia
    Yue, Wenqin
    Liu, Na
    Li, Ruobing
    Lu, Guihua
    Luo, Yanrong
    Yang, Jianmin
    ANNALS OF HEMATOLOGY, 2024, 103 (02) : 575 - 582
  • [23] Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma
    Zhang, Lihong
    Yang, Haifei
    Qian, Chongsheng
    Zhou, Jihao
    Zhu, Qian
    Jiang, Yibin
    Liu, Shuo
    Chen, Xiaochen
    Xu, Ting
    Qu, Changju
    Li, Caixia
    Jin, Zhengming
    Chu, Jianhong
    Zhang, Xinyou
    Wu, Depei
    Huang, Haiwen
    HEMATOLOGY, 2022, 27 (01) : 404 - 411
  • [24] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Greco, M.
    Fontana, A.
    Specchia, G.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Rana, A.
    Ditonno, P.
    Ferrara, F.
    Musto, P.
    Pastore, D.
    Scime, R.
    Pellegrini, F.
    Capalbo, S.
    Cavallaro, A. Maria
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S177 - S177
  • [25] Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma
    Przepiorka, D
    van Besien, K
    Khouri, I
    Hagemeister, F
    Samuels, B
    Folloder, J
    Ueno, NT
    Molldrem, J
    Mehra, R
    Körbling, M
    Giralt, S
    Gajewski, J
    Donato, M
    Cleary, K
    Claxton, D
    Braunschweig, I
    Andersson, B
    Anderlini, P
    Champlin, R
    ANNALS OF ONCOLOGY, 1999, 10 (05) : 527 - 532
  • [26] Cytoreduction and stem cell mobilization with a regimen of paclitaxel, etoposide and cyclophosphamide followed by autologous transplantation using a preparative regimen of busulfan, etoposide and cyclophosphamide for patients with advanced lymphoma
    Tutschka, PJ
    Bilgrami, SA
    Feingold, JM
    Edwards, RL
    Bona, RD
    Naqvi, B
    Clive, J
    ACTA HAEMATOLOGICA, 2001, 105 (04) : 222 - 232
  • [27] Outcomes of BeEAM (bendamustine, etoposide, cytarabine, melphalan) Compared to BEAM (carmustine, etoposide, cytarabine, melphalan) for High Dose Chemotherapy Followed By Autologous Stem Cell Transplant
    Ninos, Cameron
    Jared, Jason
    Mably, Mary
    Reed, Michael
    Hutson, Paul
    Williams, Zachary
    Callander, Natalie S.
    Hall, Aric C.
    Hematti, Peiman
    Juckett, Mark B.
    Longo, Walter L.
    Kenkre, Vaishalee P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S132 - S132
  • [28] Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    Cogle, CR
    Moreb, JS
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Reddy, VS
    Wingard, JR
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) : 169 - 175
  • [29] Busulfan,cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    张春阳
    China Medical Abstracts (Internal Medicine), 2013, 30 (02) : 116 - 117
  • [30] Thiotepa Containing Regimen As Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared with BuCyE (Busulfan, Cyclophosphamide and Etoposide)
    Kim, Yi Rang
    Yoon, Dok Hyun
    Kim, Shin
    Lee, Kyoungmin
    Kang, Eun Hee
    Park, Jung Sun
    Yoo, Changhoon
    Kim, Jeong-eun
    Jo, Jae-Cheol
    Huh, Jooryung
    Kim, Jeong Hoon
    Lee, Sang-wook
    Suh, Cheolwon
    BLOOD, 2014, 124 (21)